HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemia.

Abstract
Thirty-eight patients with various forms of myelodysplastic syndrome (MDS) were studied for the loss of restriction fragment length polymorphism (RFLP) heterozygosity on chromosome 5q as inferential support for the presence of a growth regulatory locus in this area of the genome. Conventional chromosomal analysis was performed in addition to RFLP studies of constitutive and granulocyte DNA using five polymorphisms from chromosome 5. Allelic loss in granulocyte DNA was identified in only one patient in whom monosomy 5 had already been defined cytogenetically. These results suggest that DNA sequence loss from chromosome 5q other than that observed cytogenetically is a rare event in MDS. Thus the potential involvement of a growth regulatory gene(s), from this area of the genome, in the leukemogenic process most likely involves a more subtle genetic change.
AuthorsL Shepherd, C Cameron, P Galbraith, S Windsor, D Lillicrap
JournalLeukemia research (Leuk Res) Vol. 15 Issue 5 Pg. 297-303 ( 1991) ISSN: 0145-2126 [Print] England
PMID1675299 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
Topics
  • Alleles
  • Biopsy
  • Bone Marrow (pathology)
  • Chromosome Aberrations
  • Chromosome Banding
  • Chromosome Deletion
  • Chromosome Disorders
  • Chromosomes, Human, Pair 5
  • DNA, Neoplasm (blood, genetics, isolation & purification)
  • Humans
  • Myelodysplastic Syndromes (blood, genetics, pathology)
  • Polymorphism, Restriction Fragment Length
  • Preleukemia (blood, genetics, pathology)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: